3Meteoglu I,Meydan N,Erkus M. Id-1:regulator of EGFR and VEGF and potential target for colorectal cancer therapy[J]. J Exp Clin Cancer Res,2008,27(12):69.
6Yuan TL, Cantley LC. PI3K pathway alterations in cancer: variations on a theme[J]. Oncogene,2008,27(41) :5497-5510.
7Grant S. Cotargeting survival signaling pathways in cancer[J]. J Clin Invest,2008,118(9) :3003-3006.
8Dowlati A, Nethery D, Kern JA. Combined inhibition of epidermal growth factor receptor and JAK/STAT pathways results in greater growth inhibition in vitro than single agent therapy[J]. Mol Cancer Ther,2004,3(4):459-463.
9Antonacopoulou AG, Tsamandas AC, Petsas T, et al. EGFR, HER-2 and COX-2 levels in colorectal cancer [ J ]. Histopathology,2008,53(6) :698-706.
10Yang D, Schneider S,Azuma M,et al. Gene expression levels of epidermal growth factor receptor, survivin, and vascular endothelial growth factor as molecular markers of lymph node involvement in patients with locally advanced rectal cancer[J]. Clin Colorectal Cancer, 2006,6(4): 305-311.
2Yoshiyuki T, Shmizu Y,Onda M, et al. Immunohistochemical demonstration of epidermal growth factor in human gastric cancer cenografts of mudemice[ J ]. Cancer, 1990,65 (2) :953 - 954.
3Toderud G. Epidermal growth factor, the receptor and its function[ J].Biofactors, 1989,2 ( 1 ) :11 - 12.
4Khazaie K, Bodner J. Correlations of oncogene and epidermal growth factor receptor[ J]. Oncogene, 1991,6( 1 ) :21 -28.
5Tanaks S, Haruma K, Tatsuta S, et al. Proliferating cell nuclear antigen expression correlates with the metastatic potential of sulymucosal invasive colorectal carcinoma[ J ]. Oncology, 1995,52 ( 1 ) : 134 - 138.
6Witters L, Kumar R, Mandal M, et al. Antisense oligonucleotides to the epidermal growth factor receptor[J] . Breast Cancer Res Treat,1999,53: 41-50.
7Naruse I, Ohmori T, Ao Y, et al. Antitumor activity of the selective epidermal growth factor receptortyrosine kinase inhibitor (EGFR-TKI) Iressa (ZD1839) in an EGFR expressing multi- drug resistant cell line in vitro and in vivo [J]. Int J Cancer, 2002,98: 310-315.
8Rusch V, Baselga J, Cordon-Cardo C, et al. Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung[J]. Cancer Res,1993,53: 2379-2385.
9Cunningham D, Humblet Y, Siena S, et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer [J]. N Engl J Med,2004,351: 337-345.
10Hisashi N, Koshi M, Mitsuhiko O, et al. Somatic Mutations of Epidermal Growth Factor Receptor in Colorectal Carcinoma[J]. Clinical Cancer Research, 2005, 11 : 1368- 1371.
